CVCatarina Vasco

Catarina Vasco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Catarina Vasco has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Ana C. Moreira

    I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal

    1 shared publication
  • Ana G. Santos

    I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal

    1 shared publication
  • Ana Rita Antunes

    I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal

    1 shared publication
  • Andreia Gonçalves

    I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal

    1 shared publication
  • Beatriz Porto

    Laboratório de Citogenética, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal

    1 shared publication
  • Cláudia Oliveira

    Cytogenetics Laboratory, Department of Microscopy, ICBAS—School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal

    1 shared publication

Latest Publications

  • Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice

    by Tiago L. Duarte, Marta Lopes, Mónica Oliveira, Ana G. Santos, Catarina Vasco, Joana P. Reis, Ana Rita Antunes, Andreia Gonçalves, Sérgio Chacim, Cláudia Oliveira, et al.

    Iron overload (IOL) is hypothesized to contribute to dysplastic erythropoiesis. Several conditions, including myelodysplastic syndrome, thalassemia and sickle cell anemia, are characterized by ineffective erythropoiesis and IOL. Iron is pro-oxidant and may participate in the pathophysiology of these conditions by increasing genomic instability and altering the microenvironment. There is, however, lack of in vivo evidence demonstrating a role of IOL and oxidative damage in dysplastic erythropoiesis. NRF2 transcription factor is the master regulator of antioxidant defenses, playing a crucial role in the cellular response to IOL in the liver. Here, we crossed Nrf2−/− with hemochromatosis (Hfe−/−) or hepcidin-null (Hamp1−/−) mice. Double-knockout mice developed features of ineffective erythropoiesis and myelodysplasia including macrocytic anemia, splenomegaly, and accumulation of immature dysplastic bone marrow (BM) cells. BM cells from Nrf2/Hamp1−/− mice showed increased in vitro clonogenic potential and, upon serial transplantation, recipients disclosed cytopenias, despite normal engraftment, suggesting defective differentiation. Unstimulated karyotype analysis showed increased chromosome instability and aneuploidy in Nrf2/Hamp1−/− BM cells. In HFE-related hemochromatosis patients, NRF2 promoter SNP rs35652124 genotype TT (predicted to decrease NRF2 expression) associated with increased MCV, consistent with erythroid dysplasia. Our results suggest that IOL induces ineffective erythropoiesis and dysplastic hematologic features through oxidative damage in Nrf2-deficient cells.